NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Mitel Networks Corporation (NASDAQ:MITL), Celestica, Inc. (NYSE:CLS),  CoreCivic, Inc. (NYSE:CXW), Jazz Pharmaceuticals PLC (NASDAQ:JAZZ), Open Text Corporation (NASDAQ:OTEX), and ChemoCentryx, Inc. (NASDAQ:CCXI), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

MITL DOWNLOAD: http://Fundamental-Markets.com/register/?so=MITL
CLS DOWNLOAD: http://Fundamental-Markets.com/register/?so=CLS
CXW DOWNLOAD: http://Fundamental-Markets.com/register/?so=CXW
JAZZ DOWNLOAD: http://Fundamental-Markets.com/register/?so=JAZZ
OTEX DOWNLOAD: http://Fundamental-Markets.com/register/?so=OTEX
CCXI DOWNLOAD: http://Fundamental-Markets.com/register/?so=CCXI

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Mitel Networks Corporation (NASDAQ:MITL), Celestica, Inc. (NYSE:CLS),  CoreCivic, Inc. (NYSE:CXW), Jazz Pharmaceuticals PLC (NASDAQ:JAZZ), Open Text Corporation (NASDAQ:OTEX), and ChemoCentryx, Inc. (NASDAQ:CCXI) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 1st, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

MITEL NETWORKS CORPORATION (MITL) REPORT OVERVIEW

Mitel Networks' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Mitel Networks reported revenue of $313.80MM vs $223.10MM (up 40.65%) and basic earnings per share -$0.17 vs -$0.17. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Mitel Networks reported revenue of $1,059.10MM vs $987.60MM (up 7.24%) and basic earnings per share -$0.41 vs -$1.79. Mitel Networks is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.00. The estimated EPS forecast for the next fiscal year is -$0.02 and is expected to report on February 28th, 2019.

To read the full Mitel Networks Corporation (MITL) report, download it here: http://Fundamental-Markets.com/register/?so=MITL

-----------------------------------------

CELESTICA, INC. (CLS) REPORT OVERVIEW

Celestica's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Celestica reported revenue of $1,499.70MM vs $1,482.10MM (up 1.19%) and basic earnings per share $0.10 vs $0.16 (down 37.50%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Celestica reported revenue of $6,110.50MM vs $6,016.50MM (up 1.56%) and basic earnings per share $0.73 vs $0.96 (down 23.96%). Celestica is expected to report earnings on July 24th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.24.

To read the full Celestica, Inc. (CLS) report, download it here: http://Fundamental-Markets.com/register/?so=CLS

-----------------------------------------

CORECIVIC, INC. (CXW) REPORT OVERVIEW

CoreCivic, Inc.'s Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017,  CoreCivic, Inc. reported revenue of $440.92MM vs $445.68MM (down 1.07%) and basic earnings per share $0.32 vs $0.42 (down 23.81%). For the twelve months ended December 31st, 2017 vs December 31st, 2016,  CoreCivic, Inc. reported revenue of $1,765.50MM vs $1,849.79MM (down 4.56%) and basic earnings per share $1.51 vs $1.87 (down 19.25%).  CoreCivic, Inc. is expected to report earnings on August 6th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.59. The estimated EPS forecast for the next fiscal year is $2.24 and is expected to report on February 13th, 2019.

To read the full  CoreCivic, Inc. (CXW) report, download it here: http://Fundamental-Markets.com/register/?so=CXW

-----------------------------------------

JAZZ PHARMACEUTICALS PLC (JAZZ) REPORT OVERVIEW

Jazz Pharmaceuticals' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Jazz Pharmaceuticals reported revenue of $444.61MM vs $376.05MM (up 18.23%) and basic earnings per share $0.77 vs $1.44 (down 46.53%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Jazz Pharmaceuticals reported revenue of $1,618.69MM vs $1,487.97MM (up 8.79%) and basic earnings per share $8.13 vs $6.56 (up 23.93%). Jazz Pharmaceuticals is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.72. The estimated EPS forecast for the next fiscal year is $14.04 and is expected to report on February 26th, 2019.

To read the full Jazz Pharmaceuticals PLC (JAZZ) report, download it here: http://Fundamental-Markets.com/register/?so=JAZZ

-----------------------------------------

OPEN TEXT CORPORATION (OTEX) REPORT OVERVIEW

Open Text's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Open Text reported revenue of $685.88MM vs $593.13MM (up 15.64%) and basic earnings per share $0.22 vs $0.08 (up 175.00%). For the twelve months ended June 30th, 2017 vs June 30th, 2016, Open Text reported revenue of $2,291.06MM vs $1,824.23MM (up 25.59%) and basic earnings per share $4.04 vs $1.17 (up 245.30%). Open Text is expected to report earnings on August 2nd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.17. The estimated EPS forecast for the next fiscal year is $0.61 and is expected to report on August 2nd, 2018.

To read the full Open Text Corporation (OTEX) report, download it here: http://Fundamental-Markets.com/register/?so=OTEX

-----------------------------------------

CHEMOCENTRYX, INC. (CCXI) REPORT OVERVIEW

ChemoCentryx's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, ChemoCentryx reported revenue of $9.55MM vs $8.23MM (up 15.99%) and basic earnings per share -$0.19 vs -$0.12. For the twelve months ended December 31st, 2017 vs December 31st, 2016, ChemoCentryx reported revenue of $82.50MM vs $11.94MM (up 591.22%) and basic earnings per share $0.37 vs -$0.86. ChemoCentryx is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.19. The estimated EPS forecast for the next fiscal year is -$1.18 and is expected to report on March 8th, 2019.

To read the full ChemoCentryx, Inc. (CCXI) report, download it here: http://Fundamental-Markets.com/register/?so=CCXI

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.